Category Archives: ENDS

FDA should drop its draft guidance to allow some sales of flavored e-cigs because it ignores evidence that harm to youth outweighs theoretical benefits to adults

My colleagues and I just submitted this public comment to FDA opposing its proposal to allow sales of flavored e-cigarettes and other electronic nicotine delivery systems (ENDS) on the grounds that benefits to adults would outweigh harms to kids. It also presents evidence that two-way communication between ENDS and external agencies (that could include ENDSContinue reading “FDA should drop its draft guidance to allow some sales of flavored e-cigs because it ignores evidence that harm to youth outweighs theoretical benefits to adults”